Deficiency of NRH:Quinone Oxidoreductase 2 Increases Susceptibility to 7,12-Dimethylbenz( a )anthracene and Benzo( a )pyrene-Induced Skin Carcinogenesis
- 1 September 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (17), 5925-5928
- https://doi.org/10.1158/0008-5472.can-04-0763
Abstract
NRH:Quinone oxidoreductase 2 (NQO2) is an enzyme that catalyzes the reductive metabolism of quinones. C57BL/6 NQO2−/− mice lacking NQO2 gene expression were generated in our laboratory. The dorsal skin of NQO2-deficient mice was exposed to 7,12-dimethylbenz(a)anthracene (DMBA) or benzo(a)pyrene alone (complete carcinogen) or with 12-O-tetradecanoylphorbol-13-acetate (TPA) (initiation/promotion model) to determine the in vivo role of NQO2 in chemical carcinogenesis. The NQO2−/− mice showed significantly increased tumor frequency with DMBA + TPA when compared with their wild-type littermates. The benzo(a)pyrene + TPA also showed increase in tumor incidence in NQO2−/− mice but to a less extent than DMBA. DMBA alone resulted in low frequency of tumor development with no difference in susceptibility between wild-type and NQO2−/− mice. Benzo(a)pyrene alone failed to induce tumors in either wild-type or NQO2−/− mice. Histologic analysis of the NQO2−/− mice tumors demonstrated proliferative activity. The treatment of NQO2−/− mice skin with benzo(a)pyrene failed to significantly increase tumor suppressor protein p53 and p53-regulated growth-related protein p21 and proapoptotic protein Bax as observed in case of wild-type mice. These results demonstrate that NQO2 protects against DMBA- and benzo(a)pyrene-induced skin carcinogenesis and suggest that NQO2 protection might be against tumor promotion. The results also suggest that lack of induction of p53, p21, and Bax proteins might contribute to increased sensitivity of NQO2−/− mice skin to benzo(a)pyrene carcinogenicity.Keywords
This publication has 17 references indexed in Scilit:
- Interaction of Human NAD(P)H:Quinone Oxidoreductase 1 (NQO1) with the Tumor Suppressor Protein p53 in Cells and Cell-free SystemsPublished by Elsevier ,2003
- Disruption of Dihydronicotinamide Riboside:Quinone Oxidoreductase 2 (NQO2) Leads to Myeloid Hyperplasia of Bone Marrow and Decreased Sensitivity to Menadione ToxicityPublished by Elsevier ,2002
- In Vivo Role of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) in the Regulation of Intracellular Redox State and Accumulation of Abdominal Adipose TissueJournal of Biological Chemistry, 2001
- Crystal Structure of Human Quinone Reductase Type 2, a Metalloflavoprotein,Biochemistry, 1999
- Potency Equivalency Factors for Some Polycyclic Aromatic Hydrocarbons and Polycyclic Aromatic Hydrocarbon DerivativesRegulatory Toxicology and Pharmacology, 1998
- Disruption of the DT Diaphorase (NQO1) Gene in Mice Leads to Increased Menadione ToxicityJournal of Biological Chemistry, 1998
- Catalytic Properties of NAD(P)H:Quinone Oxidoreductase-2 (NQO2), a Dihydronicotinamide Riboside Dependent OxidoreductaseArchives of Biochemistry and Biophysics, 1997
- DT-diaphorase and cancer chemotherapyBiochemical Pharmacology, 1992
- Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6Biochemistry, 1990
- Mechanisms of induction of enzymes that protect against chemical carcinogenesisAdvances in Enzyme Regulation, 1989